Fibril aggregation inhibitory activity of the β-sheet breaker peptides: A molecular docking approach

Journal of Peptide Science

Volumn 15, Issue 3, 2009, Pages 229-234

  Chini, Maria Giovanna ^a   Scrima, Mario ^a   D'Ursi, Anna Maria ^a   Bifulco, Giuseppe ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

amyloid (A ) (1 42); sheet breaker peptides (BSBs); Molecular docking calculations

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PEPTIDE DERIVATIVE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE; PEPTIDE FRAGMENT;

ARTICLE; BETA SHEET; DRUG BINDING SITE; DRUG PROTEIN BINDING; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN AGGREGATION; CHEMISTRY; COMPUTER SIMULATION; PROTEIN SECONDARY STRUCTURE;

AMYLOID BETA-PROTEIN; COMPUTER SIMULATION; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY;

EID: 63449099645     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1095     Document Type: Article

References (48)

1. Selkoe D. The molecular pathology of Alzheimer's disease. Neuron 1991; 6: 487-498.
2. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004; 44: 181-193.
3. Sipe JD, Cohen AS. Review: history of the amyloid fibril. J. Struct. Biol. 2000; 130: 88-98.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
5. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399(6738 Suppl): A23-A31.
6. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS. The Toxicity in vitro of beta-amyloid protein. Biochem. J. 1995; 311: 1-16.
7. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA. Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol. Aging 2001; 22: 131-146.
8. Robinson SR, Bishop GM. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol. Aging 2002; 23: 1051-1072.
9. Stains CI, Mondal K, Ghosh I. Molecules that target beta-amyloid. ChemMedChem 2007; 2: 1674-1692.
10. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J. Mol. Biol. 1992; 228: 460-473.
11. Soto C, Castaño E, Kumar R, Beavis R, Frangione B. Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure. Neurosci. Lett. 1995; 200: 105-108.
12. Tjernberg LO, Näslund J, Lindquist F, Johansson J, Karlström AR, Thyberg J, Terenius L, Nordstedt C. Arrest of β-Amyloid Fibril Formation by a Pentapeptide Ligand. J. Biol. Chem. 1996; 271: 8545-8548.
13. Narayanan S, Reif B. Characterization of chemical exchange between soluble and aggregated states of β-amyloid by solution-state NMR upon variation of salt conditions. Biochemistry 2005; 44: 1444-1452.
14. Cairo CW, Strzelec A, Murphy RM, Kiessling LL. Affinity-based inhibition of beta-amyloid toxicity. Biochemistry 2002; 41: 8620-8629.
15. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castaño EM, Frangione B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implication fro Alzheimer's therapy. Nat. Med. 1998; 4: 822-826.
16. Etienne MA, Aucoin JP, Fu Y, McCarley RL, Hammer RP. Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids. J. Am. Chem. Soc. 2006; 128: 3522-3523.
17. Gordon DJ, Sciarretta KL, Meredith SC. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry 2001; 40: 8237-8245.
18. Gordon DJ, Meredith SC. Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions. Biochemistry 2003; 42: 475-485.
19. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 1995; 117: 5179-5197.
20. Weiner PK, Kollman PA. AMBER: assisted model building with energy refinement. A general program for modeling molecules and their interactions. J. Comput. Chem. 1981; 2: 287-303.
21. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S Jr, Weiner PK. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 1984; 106: 765-784.
22. Mohamadi F, Richards NG, Guida WC, Liskamp R, Lipton M, Caufield C, Chang G, Hendrickson T, Still WC. MacroModel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 1990; 11: 440-467.
23. MacroModel, Version 8.5. Schrödinger LLC: New York, 2003.
24. Still WC, Tempczyk A, Hawley RC, Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990; 112: 6127-6129.
25. 13C NMR chemical shifts of natural products. Magn. Reson. Chem. 2004; 42: S26-S33.
26. Cancès MT, Mennucci B, Tomasi J. A new integral equation formalism for the polarizable continuum model: theoretical background and applications to isotropic and anisotropic dielectrics. J. Chem. Phys. 1997; 107: 3032-3041.
27. Gaussian 03, Revision E.01, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian, Inc.: Wallingford, CT, 2004.
28. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998; 19: 1639-1662.
29. Hetènyi C, Körtvèlyesi T, Penke B. Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of alzheimer's disease. Bioorg. Med. Chem. 2002; 10: 1587-1593.
30. Serpell LC, Fraser PE, Sunde M. X-ray fiber diffraction of amyloid fibrils. Methods Enzymol. 1999; 309: 526-536.
31. Kirschner DA, Inouye H, Duffy LK, Sinclair A, Lind M, Selkoe DJ. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 6953-6957.
32. Halverson KJ, Sucholeiki I, Ashburn TT, Lansbury PT Jr. Location of b eta-Sheet-forming sequences in amyloid proteins by FTIR. J. Am. Chem. Soc. 1991; 113: 6701-6703.
33. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J.Mol. Biol. 1991; 218: 149-163.
34. Krimm S, Bandekar J. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv. Protein Chem. 1986; 38: 181-364.
35. Tycko R. Solid-state nuclear magnetic resonance techniques for structural studies of amyloid fibrils. Methods Enzymol. 2001; 339: 390-413.
36. Crescenzi O, Tomaselli S, Guerrini R, Salvadori S, D'Ursi AM, Temussi PA, Picone D. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur. J. Biochem. 2002; 269: 5642-5648.
37. D'Ursi AM, Armenante MR, Guerrini R, Salvadori S, Sorrentino G, Picone D. Solution structure of amyloid beta-peptide (25-35) in different media. J. Med. Chem. 2004; 47: 4231-4238.
38. George AR, Howlett DR. Computationally derived structural models of the β-amyloid found in Alzheimer's disease plaques and the interaction with possible aggregation inhibitors. Biopolymers 1999; 50: 733-741.
39. Lansbury PT Jr, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RG, Tidor B, Griffin RG. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 1995; 2: 990-998.
40. Tjernberg LO, Callaway DJE, Tjernberg A, Hahne S, Lilliehook C, Terenius L, Thyberg J, Nordstedt C. A molecular model of Alzheimer amyloid b-peptide fibril formation. J. Biol. Chem. 1999; 274: 12619-12625.
41. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 2000; 39: 13748-13759.
42. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 13045-13050.
43. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 13407-13412.
44. Gregory DM, Benzinger TL, Burkoth TS, Miller-Auer H, Lynn DG, Meredith SC, Botto RE. Dipolar recoupling NMR of biomolecular self-assemblies: determining inter- and intrastrand distances in fibrilized Alzheimer's beta-amyloid peptide. Solid State Nucl. Magn. Reson. 1998; 13: 149-166.
45. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. Two-dimensional structure of β-amyloid (10-35) fibrils. Biochemistry 2000; 39: 3491-3499.
46. Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 17342-17347.
47. Hoyer W, Gronwall W, Jonsson A, Stahl S, Hard T. Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation. Proc. Natl. Acad. Sci.U.S.A. 2008; 105: 5099-5104.
48. Chena Z, Krausea G, Reif B. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils. J. Mol. Biol. 2005; 354: 760-776.